Stretch resistant vaso-occlusive coils

Abstract: This is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprising a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch-resisting member extending through the lumen formed, which stretch -resisting member is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch resisting member is preferably somewhat loose within the interior of the lumen so to prevent the coil from collapsing, binding, and therefore stiffening during passage of turns through the human body. The coil should bend easily. In some variations of the invention, the stretch-resisting member may be formed into coil tips at the ends of the coil using simple equipment such as soldering irons or the like. Tbe tips are typically of the same diameter as is the coil body itself. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, e.g., by retrieval or repositioning after deployment. The device may have a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. Desirably, the coil is extremely flexible and is controllaby released using a severable or mechanical joint such as an electrolytically detachable joint. External fibers may be attached to the device and affixed to the pre-formed linear member to increase thrombogenicity. The extremely flexible variation of the invention may be hydraulically delivered through the lumen of a catheter and is so flexible that it may be retrievably delivered therethrough a flow-directed catheter. The vaso-occlusive member may be also be covered with a fibrous braid. The device is typically introduced into the body through a catheter. The device is passed axially through the catheter sheath and assumes its secondary form upon exiting the catheter.

Description: This invention is an implantable vaso-occlusive device. It is typically a vaso-occlusive coil comprising a primary helically wound coil which may then be wound into a secondary shape. Central to the invention is the use of a stretch-resisting member extending through the lumen formed, which stretch-resisting member is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch resisting member is preferably somewhat loose within the interior of the lumen so to prevent the coil from collapsing, binding, and therefore stiffening during passage of turns through the human body. The coil should bend easily. In some variations of the invention, the stretch-resisting member may be formed into coil tips at the ends of the coil using simple equipment such as soldering irons or the like. The tips are typically of the same diameter as is the coil body itself. This stretch-resisting member is for the primary purpose of preventing stretching of the coil during movement of that coil, e.g., by retrieval or repositioning after deployment. The device may have a self-forming secondary shape made from a pre-formed primary linear helically wound coil, although it need not have the secondary form. Desirably, the coil is extremely flexible. The coil is controllaby released using an electrolytically detachable joint. External fibers may be attached to the device and affixed to the pre-formed linear member to increase thrombogenicity. The extremely flexible variation of the invention may be hydraulically delivered through the lumen of a catheter and is so flexible that it may be retrievably delivered therethrough a flow-directed catheter. The vaso-occlusive member may be also be covered with a fibrous braid. The device is typically introduced into the body through a catheter. The device is passed axially through the catheter sheath and assumes its secondary form upon exiting the catheter. Vaso-occlusion devices are surgical implements or implants that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature via the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. One widely used vaso-occlusive device is a helical wire coil having windings which may be dimensioned to engage the walls of the vessels. Other less stiff, helically coiled devices have been described, as well as those involving woven braids. Virtually all such vaso-occlusive implants are delivered by wire-guided catheters which devices are pushed through the catheter. Because of the need for a pusher and concerns for recovery of such vaso-occlusive devices should they be malplaced in the body, it is unlikely that prior to this invention has there been a vaso-occlusive device of a form similar to this delivered through a flow directed catheter. As an instance of an early vaso-occlusive device, US Patent No. 4,994,069; to Ritchart et al., describes a vaso-occlusive coil that assumes a linear helical configuration when stretched and a folded, convoluted configuration when relaxed. The stretched condition is used in placing the coil at the desired site (by its passage through the catheter) and the coil assumes a relaxed configuration --which is better suited to occlude the vessel -- once the device is so placed. Ritchart et al. describes a variety of shapes. The secondary shapes of the disclosed coils include "flower" shapes and double vortices. A random secondary shape is described, as well. Vaso-occlusive coils having attached fibrous elements in a variety of secondary shapes are shown in US Patent No. 5,304,194, to Chee et al. Chee et al. describes a helically wound device having a secondary shape in which the fibrous elements extend in a sinusoidal fashion down the length of the coil. These coils, as with Ritchart et al., are produced in such a way that they will pass through the lumen of a catheter in a generally straight configuration and, when released from the catheter, form a relaxed or folded shape in the lumen or cavity chosen within the human body. The fibrous elements shown in Chee et al. enhance the ability of the coil to fill space within the vasculature and to facilitate formation of embolus and subsequent allied tissue. There are a variety of ways of discharging shaped coils and linear coils into the human vasculature. In addition to those patents which apparently describe only the physical pushing of a coil out into the vasculature (e.g., Ritchart et al.), there are a number of other ways to release the coil at a specifically chosen time and site. US Patent No. 5,354,295 and its parent, 5,122,136, both to Guglielmi et al., describe an electrolytically detachable embolic device. A variety of mechanically detachable devices are also known. For instance, US Patent No. 5,234,437, to Sepetka, shows a method of unscrewing a helically wound coil from a pusher having interlocking surfaces. US Patent No. 5,250,071, to Palermo, shows an embolic coil assembly using interlocking clasps mounted both on the pusher and on the embolic coil. US Patent No. 5,261,916, to Engelson, shows a detachable pusher-vaso-occlusive coil assembly having an interlocking ball and keyway-type coupling. US Patent No. 5,304,195, to Twyford et al., shows a pusher-vaso-occlusive coil assembly having an affixed, proximally extending wire carrying a ball on its proximal end and a pusher having a similar end. The two ends are interlocked and disengage when expelled from the distal tip of the catheter. US Patent No. 5,312,415, to Palermo, also shows a method for discharging numerous coils from a single pusher by use of a guidewire which has a section capable of interconnecting with the interior of the helically wound coil. US Patent No. 5,350,397; to Palermo et al., shows a pusher having a throat at its distal end and a pusher through its axis. The pusher sheath will hold onto the end of an embolic coil and will then be released upon pushing the axially placed pusher wire against the member found on the proximal end of the vaso-occlusive coil. Vaso-occlusive coils having little or no inherent secondary shape have also been described, for instance in WO 94/10936. This document, upon which the preamble of claim 1 is based, discloses a coil having little or no shape after introduction into the vascular space. None of these devices are helical coils which contain a stretch-resisting member contained therein. US-A-5 217 484 discloses a vaso-occlusive device comprising: (i) a helically wound coil having a proximal end, a distal end and a lumen defined between said ends; (ii) a stretch-resisting member extending through said lumen and fixedly attached to said primary coil in at least two locations; and (iii) means provided at the proximal end for releasable mechanical attachment to a pusher. EP-A-0 754 435 is relevant as prior art to the present invention under Article 54(3) EPC only. It also discloses a vaso-occlusive device having all of the features of the device of US-A-5 217 484. Furthermore, the device disclosed in EP-A-0 754 435 additionally discloses the possibility of the stretch-resisting member comprising a polymer, as well as the possibility of the deployment tip comprising an electrolytically detachable end adapted to detach from a pusher by imposition of an electric current on said pusher. According to the present invention there is provided a vaso-occlusive device comprising: (i) an outer helically wound primary coil having a first end, a second end and a lumen defined between said first and second ends, the primary coil having a flexibility such that a free end of the primary coil will droop more than about 20° when the primary coil is held horizontally one centimetre from the free end; and (ii) a deployment tip attached to at least one of said first and second ends, said deployment tip comprising an electrolytically detachable end adapted to detach from a pusher by imposition of an electric current on said pusher, characterised in that the device further comprises: (iii) a polymeric stretch-resisting member extending through said lumen and fixedly attached to said primary coil in at least two locations. Accordingly, this invention relates to a vaso-occlusive device comprising a helically wound coil which is formed by winding a wire into a first or primary helix to form an outer helical member having first and second ends. A polymeric stretch resistant member extending through the lumen thus-formed is fixedly attached, directly or indirectly, to the coil in at least two locations. The stretch-resisting member is preferably loose within the coil to prevent binding of the coil during passage of the coil through turns in the vasculature. The primary helix may be wound into a secondary form and heat-treated to preserve that form, desirably prior to the step of including the stretch-resisting member into the coil. The secondary form may be one which, when ejected from a delivery catheter, forms a specific shape. Such a shape might, e.g., fill a vascular cavity such as an aneurysm, or perhaps, a fistula or AVM. The stiffness of the various parts of the coil may be tailored to enhance the utility of the device for specific applications. Extremely flexible coils are highly desirable. Fibrous materials may be woven into the member or tied or wrapped onto it to enhance the thrombogenicity. The device may be used simply by temporarily straightening the device, as necessary, and introducing it into a suitable catheter, the catheter already having been situated so that its distal opening is at the selected site in the body. The device is then pushed through the catheter and, upon its ejection from the distal end of the catheter into the vascular cavity, assumes its relaxed or secondary shape. The device is typically used in the human vasculature to form emboli but may be used at any site in the human body whore an occlusion such as one produced by the inventive device is needed. Also forming an important aspect of this invention is the combination of this inventive vaso-occlusive device with a flow-directed catheter. The present invention will be more clearly understood from the following description, given by way of example only, with reference to the accompanying drawings. Figures 1, 2A, 2B, 2C, 4, 5, 6, 7 and 8 all show devices which, in the exact form illustrated, are not in accordance with the present invention in that they do not show a deployment tip having an electrolytically detachable end. When employed with a deployment tip of the form claimed in claim 1, and comprising a coil and polymeric stretch-resisting member as set out in the characterising portion of claim 1, these devices are in accordance with the present invention. When the devices illustrated in Figures 3A, 3B and 3C comprise coils and polymeric stretch-resisting members as set out in the characterising portion of claim 1, these devices are also in accordance with the present invention. There now follows a brief description of the various drawings. Figure 1 shows a side view, partial cutaway of a vaso-occlusive coil having a generally linear fibrous stretch-resisting member. Figures 2A, 2B, and 2C show side view, partial cutaways of typical ends of vaso-occlusive coils. Figures 3A, 3B, and 3C show side view cutaways of electrolytically severable joints in combination with a vaso-occlusive coil. Figure 4 shows a "C" shaped secondary configuration for a vaso-occlusive device. Figure 5 shows a clover-leaf secondary shape for a vaso-occlusive device. Figure 6 shows a double-looped secondary shape for a vaso-occlusive device. Figure 7 shows attachment of external fibrous material to a vaso-occlusive device. Figure 8 shows attachment of external braided fibrous material to a vaso-occlusive device. Figure 9 shows the combination of the vaso-occlusive device of this invention in assembly with a flow-directed catheter. Figures 10A-10D show a procedure for introducing a vaso-occlusive coil such as found in the other Figures into an aneurysm. Figure 1 shows a side-view partial cross-section (or cutaway) of a vaso-occlusive device (100). The device shown in Figure 1 is made up of a helically wound outer coil (102) having a first end (104) and a second end (106). We refer to this form as the "primary" winding or shape. This variation includes a stretch-resisting member (108) which is shown to be fixedly attached both to the first end (104) and to the second end (106). In certain circumstances, it may be desirable to attach the stretch-resisting member (108) only to one of the two ends, to at least one site between the two ends, or to neither of the two ends. Clearly, for attaining stretch resistance, the stretch resisting member must be attached to at least two points on the coil. The stretch-resisting member (108) of the device shown in Figure 1 is fibrous and polymeric. The stretch-resisting member (108) may be thermoplastic or thermosetting and comprise a bundle of threads or a single filament melted onto, glued, or otherwise fixedly attached to the vaso-occlusive coil (100). In some instances, it may also be desirable to include one or more metallic strands in the stretch-resisting member (108) to provide stiffness or electrical conductance for specific applications. The materials used in constructing the vaso-occlusive coil (102) may be any of a wide variety of materials, preferably, a radio-opaque material such as a metal or a polymer is used. Suitable metals and alloys for the wire making up the primary coil (102) include the Platinum Group metals; especially platinum; rhodium, palladium, rhenium, as well as tungsten, gold, silver, tantalum; and alloys of these metals. These metals have significant radio-opacity and in their alloys may be tailored to accomplish an appropriate blend of flexibility and stiffness. They are also largely biologically inert. Highly preferred is a platinum/tungsten alloy, e.g., 8% tungsten and the remainder platinum. If a super-elastic alloy such as nitinol is used in the device, the diameter of the coil wire may be significantly smaller than that used when the relatively more ductile platinum or platinum/tungsten alloy is used as the material of construction. The coils may be made of radiolucent fibers or polymers (or metallic threads coated with radiolucent or radio-opaque fibers) such as Dacron (polyester); polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or even cotton or silk. Should a polymer be used as the major component of the vaso-occlusive coil member, it is desirably filled with some amount of a radio-opaque material such as powdered tantalum, powdered tungsten, bismuth oxide, barium sulfate, and the like. The coil material is first wound into a primary coil (102). The primary coil is typically linear after it has been wound. Generally speaking, when the coil (102) is a metallic coil and that coil is a platinum alloy or a super-elastic alloy such as nitinol, the diameter of the wire used in the production of the coil (102) will be in the range of 0.0064 and 0.152 mm (0.00025 and 0.006 inches). The wire is wound into a primary coil (102) having a primary diameter of between 0.076 and 0.635 mm (0.003 and 0.025 inches). For most neurovascular indications, the preferable primary coil (102) diameter is 0.2 to 0.46 mm (0.008 to 0.018 inches). We have generally found that the coil wire may be of sufficient diameter to provide a hoop strength to the resulting device sufficient to hold the device in place within the chosen body site lumen or cavity, without substantially distending the wall of the site and without moving from the site as a result of the repetitive fluid pulsing found in the vascular system. However, the invention provides the user with extremely flexible coil assemblies having very high packing efficiencies. For instance, coil wires having wire diameters of 0.0038 mm (0.00015")and less are suitable for such highly flexible devices. Typically the coil diameter will be 0.38 mm (0.015") and less. They will "droop" more than about 20°, preferably 35° to 90° when about 1 centimeter of the primary' form of the coil having a free end is held horizontally. The axial length of the primary coil will usually fall in the range of 0.5 to 100 cm, more usually 2.0 to 40 cm. Depending upon usage, the coil may well have 10-75 turns per centimeter, preferably 10-40 turns per centimeter. All of the dimensions here are provided only as guidelines and are not critical to the invention. However, only dimensions suitable for use in occluding sites within the human body are included in the scope of this invention. Once the primary coil (102) is wound, the stretch-resisting member (108) inserted into the lumen of the primary coil (102) and secured to the coil as desired. Ends (104, 106) are preferably of the same diameter as is the primary coil (102). Suitable polymeric materials for the polymeric stretch-resisting member (108) can be either thermosetting or thermoplastic. Thermoplastics are preferred because they allow simplification of the procedure for constructing the device (100) since they may be melted and formed into the end or ends (104, 106). Simple devices such as soldering irons may be used to form the ends. Thermosetting plastics would typically be held in place by an adhesive. Suitable polymers include most biocompatible materials which may be made into fibers but include thermoplastics, e.g., polyesters such as polyethyleneterephthalate (PET) especially Dacron; polyamides including the Nylons; polyolefins such as polyethylene, polypropylene, polybutylene, their mixtures, alloys, block and random copolymers; polyglycolic acid; polylactic acid; fluoropolymers (polytetrafluoro-ethylene), or even silk. Preferred because of the long history of safe and effective usage in the human body are fibrous PET (sold as Dacron) and polypropylene. Highly preferred is polypropylene. Figure 2A shows a side-view partial cross-section of one end of a coil (100). Figure 2A also shows the helically wound outer coil (102) having an end (106) which is formed from a formerly molten fiber which also makes up the stretch-resisting member (108). An end of this type may be considered to have modestly higher vaso-occluding properties than a metallic end. Other functional equivalents to this structure include ends (106) formed of glues such as epoxies and their equivalents, and which are mechanical in nature. Figure 2B shows an external knot (112) which fixes the length of the coil member (102) and keeps it from stretching; Figure 2C shows a reformed mass of formerly molten polymer or of glue which is of a diameter larger than the inner diameter of coil (102) and prevents the coil from stretching. The knot (112) and block (114) are not shown to be attached to the coil (102) but should be. The variations shown in Figures 1, 2A, 2B, and 2C are designed to be deployed by use of a pusher and a catheter in the manner discussed in Ritchart et al, discussed above, and as illustrated are not in accordance with the present invention. When an end of the device is adapted to accept an electrolytically severable joint of the type discussed in US Patent No. 5,354,295 and its parent, 5,122,136, both patents to Guglielmi and Sepetka, described above, the resultant devices may be in accordance with the present invention. Figures 3A and 3B depict, in partial cross section, such variations. The vaso-occlusive coil (130, 230) is attached to a fill member or bushing (132, 232). The fill member or bushing (132, 232) preferably comprises a thermoplastic formed into place or an epoxy or the like and adheres, in turn, both to the stretch resistant member (134, 234) and the core wire (136, 236). The stretch-resisting member (134, 234) is thusly indirectly attached to the vaso-occlusive coil (130, 230) via the fill member or bushing (132, 232). The core wire (136, 236) in this variation has an enlarged member which is embedded in the fill member (132, 232). The core wire (136, 236) is insulated, typically with a combination of polytetrafluoroethylene and PARYLENE (polyparaxyxylene), except for a small sacrificial joint (138, 238) which is intended to be the site of the electrolysis as the joint (138, 238) is eroded or severed and the coil deployed into the body site. The details of this variation (sans stretch-resistant member (136, 236)) are discussed in Gia et al, US Patent application Serial No. 08/367,061, filed December 30, 1994, published as EP-A-719522 in July, the 3 rd 1996. Figure 3C shows a variation of the device. The assembly (131) employs a stretch-resisting member (133) which is connected indirectly to the coil (135). Specifically the stretch-resisting member (133) is a thermoplastic fiber or fibers which are melted to form a coil tip (137) at one end of the coil (135) and is looped about a hook (139) at (or in the vicinity of) the other end of the coil (135). An anchor coil (141) is coaxially situated between the vaso-occlusive coil (135) and the pusher wire (136). The hook (139) forms the final turn or half-turn of the anchor coil (141). The stretch-resisting member (133) is thusly indirectly attached to the vaso-occlusive coil (135) via the anchor coil (141). The anchor coil (141) and the vaso-occlusive coil (135) are preferably welded together. Figure 3C also shows the vaso-occlusive coil (135) in its maximum stretched condition. The stretch-resisting member (133) is shown resisting further axial stretching of the assembly. When the vaso-occlusive coil (135) is not stretched the stretch-resisting member (133) would obviously be loose, i.e., normally longer than the lumen, in the lumen of the assembly (131). If the stretch-resisting member (133) is not allowed to have such a loose axial fit, the adjacent turns of the coil (135) would "bottom" against each other during passage through turns in the vasculature and cause the assembly (131) to become stiff. The devices of this invention may have the simple linear shape shown in Figures 1 and 2 or may have shapes which are not so simple. Figures 4 to 6 show what are termed "secondary" shapes in that they are formed from the primary coil by the simple act of winding the primary coil on a form of a desired shape and then heat treating the so-formed shape. Figure 4 shows a "C" shaped coil assembly (160) having a stretch-resistant member (162). Figure 5 shows a clover-leaf shaded coil assembly (164) also having a stretch-resistant member (162). Figure 6 shows a double-loop coil assembly (166). These are indicative of the various secondary shapes suitable for this invention. Additionally, the inventive devices may also be used in conjunction with various external fiber adjuncts. Figure 7 shows a partial side-view of a linear variation of a device (170) having filamentary material (172) looping through the coil (174). This method of attachment is described in greater detail in US Pat. Nos. 5,226,911 and 5,304,194, to Chee et al. A further description of a desirable fiber attachment is shown in US Pat. application No. 08/265,188, to Mirigian et al, filed June 24, 1994. Figure 8 shows a partial cutaway of a device (180) having a braided covering (182) of a filamentary material and a stretch-resisting member (184). This method of enveloping a coil is described in greater detail in US Pat. Nos. 5.382,259, to Phelps et al. The fibrous woven or braided tubular materials may be made from a biocompatible materials such as Dacron (polyester), polyglycolic acid, polylactic acid, fluoropolymers (polytetrafluoroethylene), Nylon (polyamide), or silk. The strands forming the braid should be reasonably heavy, e.g., having tensile strength of greater than about 0.66 N (0.15 pounds). The materials mentioned, to the extent that they are thermoplastics, may be melted or fused to the coils. Alternatively, they may be glued or otherwise fastened to the coils. Preferred materials include Dacron. Figure 9 shows a highly preferred assembly incorporating a number of desirable aspects of the invention. Specifically, the very flexible inventive vaso-occlusive device noted above, e.g., wherein the vaso-occlusive device is capable of "drooping" 20° or more and having a polymeric stretch-resisting member included therein, is especially suitable for inclusion in a flow-directed catheter and particularly when used with an electrolytically severable joint. Figure 9 shows the flow-directed catheter (200) containing a very flexible vaso-occlusive coil (202) as described above and utilizing a similarly flexible stretch resisting member (204). The flow directed catheter (200) may have a distal radio-opaque marker (206) if so desired. Proximally of the vaso-occlusive coil (202) is a connective wire (208) which is insulated at all points proximal of the electrolytic joint (210). The flow directed catheter (200) may be of any known design such as is found. e.g., in U.S. Pat. No. 5,336,205, to Zenzen et al. "Flow-directed catheters" are directed to the treatment site in the human body through the vasculature by the motive power of natural blood flow. The more distal segments of flow-directed catheters are often of materials having significant elastomeric properties but with high burst strengths, e.g., polyurethane. polyvinylchloride, silicones, etc. They are often quite "rubbery" in feel. Consequently', flow directed catheters are not usually especially suitable for use with guidewires and the like. In use of this inventive vaso-occlusive device, however, since the vaso-occlusive device is so compliant and able to be delivered using hydraulic pressure alone (as with saline), they may be used with flow-directed catheters. Further. since the vaso-occlusive device (202) contains a stretch-resisting member (204), the vaso-occlusive device (202) may be withdrawn into the catheter (200) using the connective wire (208). The connective wire (208) used therein should be very flexible so not to interfere with the movement of the catheter (200) . It is conductive and insulated proximally of the electrolytic joint (210). Introduction of an electric current into the connective wire (208) will cause the electrolytic joint (210) to erode and the vaso-occlusive device (202) to become detached. Complete description of the operation of such a device is found in U.S. Patent Nos. 5,122,136 and 5,354,295, both to Guglielmi and Sepetka. Figures 10A-10D depict a common deployment method for introduction of the inventive vaso-occlusive devices described here. It may be observed that these procedures are not significantly different than those described in the Ritchart et al. patent mentioned above. Although the vaso-occlusive device illustrated in Figures 10A-10D is not shown as having an electrolytically severable joint, it will be appreciated that the deployment method is applicable to devices in accordance with the present invention with such joints. Specifically, Figure 10A shows the distal tip of a delivery catheter (310) which is within the opening (312) of an aneurysm (314) found in an artery (316). The distal end or end section of the vaso-occlusive device (318) is shown within the catheter (310). In Figure 10B, the distal end portion of the vaso-occlusive device (318) has exited the distal end of the catheter (310) and has wound into a secondary shape within the aneurysm (314). Figure 10C shows the completion of the formation of the secondary shape within the aneurysm (314). Figure 10D shows the separation of the vaso-occlusive device (318) from the pusher, placement within the aneurysm (314), and the withdrawal of the catheter from the mouth of the aneurysm. Once the inventive coil is in place in an aneurysm or other site, there may be an occasion during which the coil must be moved or even withdrawn. For instance, in Figure 10D, the coil might extend through the mouth (312) of the aneurysm into the artery. Occlusion would not be desirable in the artery. A device such as the endovascular snare shown in US Pat. No. 5,387,219, to Rappe, may then be used to grasp the exposed coil and move it or retrieve it from the body. The stretch-resisting member of this invention prevents the coil from stretching into a single strand of wire and multiplying in length.

Claims: A vaso-occlusive device comprising: (i) an outer helically wound primary coil (130,230) having a first end, a second end and a lumen defined between said first and second ends, the primary coil (130,230) having a flexibility such that a free end of the primary coil will droop more than about 20° when the primary coil is held horizontally one centimetre from the free end; and (ii) a deployment tip (138,238) attached to at least one of said first and second ends, said deployment tip (138,238) comprising an electrolytically detachable end adapted to detach from a pusher (136,236) by imposition of an electric current on said pusher, characterised in that the device further comprises: (iii) a polymeric stretch-resisting member (134,234) extending through said lumen and fixedly attached to said primary coil in at least two locations. The device of claim 1, wherein said stretch-resisting member comprises at least one fiber. The device of claim 1, wherein said stretch-resisting member comprises multiple fibers. The device of any one of the preceding claims, wherein said stretch-resisting member includes one or more metallic strands. The device of any one of the preceding claims, where the device has a secondary form. The device of any one of the preceding claims, wherein said helically wound coil comprises a metal selected from the group consisting of platinum, palladium, rhodium, gold, tungsten, and their alloys. The device of any one of the preceding claims, wherein said helically wound coil comprises an alloy of platinum and tungsten. The device of any one of claims 1 to 5, wherein said helically wound coil comprises an alloy selected from the group consisting of stainless steels and super-elastic alloys. The device of claim 8, wherein said helically wound coil comprises a nickel-titanium super-elastic alloy. The device of any one of the preceding claims, comprising a polymer containing a radio-opaque filler. The device of any one of the preceding claims, additionally comprising external filamentary material attached to said primary coil. The device of any one of the preceding claims, wherein the stretch-resisting member comprises a thermoplastic. The device of claim 12, wherein said thermoplastic comprises polyethylene terephthalate. The device of claim 12, wherein said thermoplastic comprises polypropylene. The device of any one of claims 12 to 14, wherein said thermoplastic also forms a cap located on at least one end of said primary coil. The device of claim 15, wherein said thermoplastic forms caps at both ends of said primary coil. The device of claim 15 or claim 16, wherein the or a said cap is of the same diameter as said primary coil. The device of any one of the preceding claims, wherein the stretch-resisting member adheres to at least one end of said primary coil. The device of any one of claims 1 to 17, wherein the stretch-resisting member extends through said lumen and is fixedly, indirectly attached to at least one of said first and second ends. The device of any one of claims 1 to 17, wherein the stretch-resisting member extends through said lumen and is fixedly, directly attached to at least one of said first end and second ends. The device of any one of claims 1 to 15, further comprising an anchor coil located coaxially within the lumen of the helically wound coil at least at one end of said helically wound coil. The device of claim 21, wherein the stretch-resisting member is fixedly attached to said anchor coil. The device of claim 21, wherein the stretch-resisting member is fixedly attached to a hook on said anchor coil. The device of claim 1, wherein the stretch-resisting member is loose within the lumen of said helically wound coil. The device of any one of the preceding claims, further comprising in combination a flow-directed catheter surrounding at least a portion of said helically wound primary coil.

Inventors: ENGELSON ERIK T, GIA SON M, KEN CHRISTOPHER G M, ENGELSON, ERIK T., GIA, SON M., KEN, CHRISTOPHER G.M.
Applicants: TARGET THERAPEUTICS INC, TARGET THERAPEUTICS, INC.
Application year: 1997
Main classification: A61B17
IPC codes: A61B19, A61B17, A61F2